Acadia Pharma (ACAD) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $27.94 -0.29%
Revenue Growth %: +19.1%
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +19.1%
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q4 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Freeport-McMoRan shares surge as copper hits record $14,694/ton
- JPMorgan starts FedEx Freight at Overweight on post-spin turnaround
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
